Where PeakLifeRx sits in the 503B supply chain
FDA-registered 503B outsourcing facilities produce compounded medications in bulk for office use and clinic stock under 503B federal regulations and cGMP production standards. PeakLifeRx occupies the ordering and invoicing layer above those facilities — it does not compound, manufacture, or dispense medications. It gives clinics one portal to browse a vetted catalog, submit orders, and receive consolidated invoicing across multiple 503B supply partners.
This boundary matters for evaluation. Questions about product quality, certificates of analysis, and compliance standards are ultimately about the FDA-registered 503B facilities PeakLifeRx connects to. Questions about catalog access, pricing visibility, onboarding, and support are about the platform layer itself — and that is where PeakLifeRx and alternatives like Fizy Health diverge.